Etcembly aims at cancer with AI-driven, rapid TCR engineering technology
- David Tokley
- Dec 2, 2023
- 1 min read
Caroline Richards at BioWorld explores how our AI-driven approach is enabling TCR discovery and optimisation at unprecedented scale and speed.
